Video

RISE: Insulin glargine, metformin offer no beta cell function benefit in youth

Publish date: July 11, 2018

 

EXPERT ANALYSIS AT ADA 2018

Pages

Recommended Reading

Updates on health and care utilization by TGNC youth
MDedge Endocrinology
Obesity in adults continues to rise
MDedge Endocrinology
MDedge Daily News: Is rosacea a red flag for deeper dangers?
MDedge Endocrinology
FDA approves burosumab to treat X-linked hypophosphatemia
MDedge Endocrinology
MDedge Daily News: How to handle opioid constipation
MDedge Endocrinology
Trends in teen consumption of sports drinks are up and down
MDedge Endocrinology
Patient adjustments needed for closed-loop insulin delivery
MDedge Endocrinology
Risk of adverse birth outcomes for singleton infants born to ART-treated or subfertile women
MDedge Endocrinology
Study spotlights risk factors for albuminuria in youth with T2DM
MDedge Endocrinology
Uric acid tied to pediatric diabetic kidney disease
MDedge Endocrinology